Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/26
End: 09/30/27
Due: 09/30/28
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 10/31/25
Due: 10/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease | NCT05971329 | Zetagen Therapeutics, Inc | user2@example.com | None | 2026-09-30 | 2027-09-30 | 2028-09-30 | - | - | 2025-07-14 |
| Feasibility Study of ZetaFuse(TM) Bone Graft in the Repair of Bone Defects From Metastatic Breast Cancer in the Spinal Vertebral Body | NCT05280067 | Zetagen Therapeutics, Inc | user2@example.com | None | 2022-09-01 | 2025-10-31 | 2026-10-31 | - | - | 2025-07-14 |